Gallimune ND+IB+ART inj. emuls. i.m. vial

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktīvā sastāvdaļa:

Newcastle Disease Virus (inactivated) ; Avian Rhinotracheitis Virus (inactivated) ; Avian Coronavirus (inactivated)

Pieejams no:

Boehringer Ingelheim Animal Health Belgium SA-NV

ATĶ kods:

QI01AA18

SNN (starptautisko nepatentēto nosaukumu):

Paramyxovirus (Newcastle Disease Virus), Inactivated; Turkey Rhinotracheitis Virus (TRTV); Avian Infectious Bronchitis (IB) Virus

Zāļu forma:

Emulsion for injection

Kompozīcija:

Paramyxovirus (Newcastle Disease Virus), Inactivated; Turkey Rhinotracheitis Virus (TRTV); Avian Infectious Bronchitis (IB) Virus

Ievadīšanas:

Intramuscular use

Ārstniecības grupa:

poultry

Ārstniecības joma:

Avian Infectious Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + avian adenovirus + avian rhinotracheitis virus

Produktu pārskats:

CTI code: 353875-04 - Pack size: 10 x 1000 doses (300 (300) - Commercialisation status: NO - FMD code: 03661103055044 - CNK code: 3667151 - Delivery mode: Medical prescription; CTI code: 353875-01 - Pack size: 500 doses (150 (150) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 353875-03 - Pack size: 10 x 500 doses (150 (150) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 353875-02 - Pack size: 1000 doses (300 (300) - Commercialisation status: NO - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: No

Autorizācija datums:

2009-12-01